Biocryst Pharmaceuticals Inc (BCRX)
Interest Expense
$75.29M
TTM · Period ending: · USD
BCRX Interest Expense
Latest reported$75.29Mperiod ending
Latest reported$75.29Mperiod ending
BCRX TTM Interest Expense ($0.00 → $75.29M)
TTM interest expense
High-resolution chart · PNG
BCRX interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 75,287,000 | |
| 75,157,000 | |
| 78,872,000 | |
| 89,186,000 | |
| 94,353,000 | |
| 97,504,000 | |
| 98,516,000 | |
| 98,650,000 | |
| 101,167,000 | |
| 105,349,000 | |
| 108,239,000 | |
| 110,114,000 | |
| 107,544,000 | |
| 102,651,000 | |
| 99,092,000 | |
| 91,414,000 | |
| 80,754,000 | |
| 70,227,000 | |
| 59,294,000 | |
| 46,123,000 | |
| 35,247,000 | |
| 24,670,000 | |
| 14,813,000 | |
| 12,291,000 | |
| 12,096,000 | |
| 12,213,000 | |
| 11,892,000 | |
| 11,219,000 | |
| 10,521,000 | |
| 9,681,000 | |
| 9,176,000 | |
| 8,993,000 | |
| 8,787,000 | |
| 8,686,000 | |
| 8,565,000 | |
| 8,465,000 | |
| 7,790,000 | |
| 7,117,000 | |
| 6,487,000 | |
| 5,694,000 | |
| 5,470,000 | |
| 5,355,000 | |
| 5,200,000 | |
| 5,176,000 | |
| 5,152,000 | |
| 5,071,000 | |
| 4,998,000 | |
| 4,926,000 | |
| 4,900,000 | |
| 4,840,000 | |
| 4,778,000 | |
| 4,716,000 | |
| 4,691,000 | |
| 4,686,000 | |
| 4,666,000 | |
| 4,646,000 | |
| 4,640,000 | |
| 4,646,000 | |
| 3,774,000 | |
| 2,614,000 | |
| 1,454,000 | |
| 288,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |